AC
SRPT icon

Allstate Corporation’s Sarepta Therapeutics SRPT Stock Holding History

Allstate Corporation’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$767K Buy
+35,255
New +$682K 0.01% 892
2021
Q1 		– Sell
-2,585
Closed -$441K – 741
2020
Q4 		$441K Buy
2,585
+118
+5% +$17.5K 0.01% 546
2020
Q3 		$346K Hold
2,467
– – 0.01% 534
2020
Q2 		$396K Sell
2,467
-781
-24% -$106K 0.01% 511
2020
Q1 		$318K Buy
3,248
+1,342
+70% +$153K 0.01% 482
2019
Q4 		$246K Buy
+1,906
New +$192K ﹤0.01% 580
2019
Q3 		– Sell
-6,964
Closed -$1.06M – 533
2019
Q2 		$1.06M Buy
+6,964
New +$846K 0.02% 381

Other funds holding SRPT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return